Table 1. Participant characteristics at baseline.
| Characteristics | Total cohort | Participants included in primary outcome analysisa | ||
|---|---|---|---|---|
| Intervention, n = 263 | Control, n = 260 | Intervention, n = 217 | Control, n = 213 | |
| Female, n (%) | 132 (50.2) | 156 (60.0) | 109 (50.2) | 126 (59.2) |
| Age, mean (SD) | 73 (8.4) | 73 (8.6) | 73 (8.3) | 72 (8.3) |
| Age group, n (%) | ||||
| 60–69 | 107 (40.7) | 111 (42.7) | 93 (42.9) | 93 (43.7) |
| 70–79 | 89 (33.8) | 83 (31.9) | 72 (33.2) | 68 (31.9) |
| 80–90 | 67 (25.5) | 66 (25.4) | 52 (24.0) | 52 (24.4) |
| Hours of index admission, median (IQR) | 17.9 (4.3–49.1) | 20.1 (3.6–49.2) | 15.8 (4–42.2) | 18.5 (3.5–49.2) |
| Baseline assessment | n = 224 | n = 217 | n = 217 | n = 213 |
| Lives alone, n (%) | 93 (41.5) | 94 (43.3) | 88 (40.6) | 91 (42.7) |
| Employed, n (%) | 50 (22.3) | 40 (18.4) | 48 (22.1) | 37 (17.4) |
| FROP-Comb | ||||
| Reported ≥1 fall in last 12 months (excluding index fall) | 89 (39.7) | 93 (42.9) | 83 (38.2) | 91 (42.7) |
| Most severe injury sustained from a fall in the last 12 months, n (%) | ||||
| No injuries | 4 (1.8) | 5 (2.3) | 4 (1.8) | 5 (2.3) |
| Minor injury—no medical attention | 5 (2.2) | 6 (2.8) | 5 (2.3) | 6 (2.8) |
| Minor injury—medical attention | 121 (54.0) | 92 (42.4) | 117 (53.9) | 91 (42.7) |
| Severe injury | 94 (42.0) | 114 (52.5) | 91 (41.9) | 111 (52.1) |
| Sedative medication | 37 (16.5) | 29 (13.4) | 36 (16.6) | 29 (13.6) |
| Antidepressant medication | 52 (23.2) | 51 (23.5) | 51 (23.9) | 49 (22.6) |
| Anti-epileptic medications | 15 (6.9) | 10 (4.5) | 15 (7.0) | 10 (4.6) |
| Central analgesic medications | 45 (20.1) | 52 (24.0) | 44 (20.3) | 52 (24.4) |
| Number of prescription medications, n (%) | ||||
| No medications | 16 (7.1) | 20 (9.2) | 16 (7.4) | 20 (9.4) |
| 1–2 medications | 45 (20.1) | 37 (17.1) | 42 (19.4) | 36 (16.9) |
| 3 medications | 26 (11.6) | 33 (15.2) | 25 (11.5) | 32 (15.0) |
| 4 or more medications | 137 (61.2) | 127 (58.5) | 134 (61.8) | 125 (58.7) |
| Medical conditions reported by participants, n (%) | ||||
| Arthritis | 86 (38.4) | 103 (47.5) | 83 (38.2) | 102 (47.9) |
| Cardiac condition | 72 (32.1) | 68 (31.3) | 68 (31.3) | 66 (31.0) |
| Respiratory condition | 52 (23.2) | 44 (20.3) | 50 (23.0) | 44 (20.7) |
| Diabetes | 45 (20.1) | 38 (17.5) | 44 (20.3) | 37 (17.4) |
| Osteoporosis | 36 (16.1) | 34 (15.7) | 33 (15.2) | 34 (16.0) |
| Stroke | 18 (8.0) | 23 (10.6) | 18 (8.3) | 22 (10.3) |
| Other | 73 (32.6) | 71 (32.7) | 71 (32.7) | 70 (32.9) |
| Number of comorbidities, n (%) | ||||
| None | 53 (23.7) | 44 (20.3) | 51 (23.5) | 42 (19.7) |
| 1 | 55 (24.6) | 53 (24.4) | 55 (25.3) | 53 (24.9) |
| 2 | 53 (23.7) | 56 (25.8) | 52 (24.0) | 55 (25.8) |
| ≥3 | 63 (28.1) | 64 (29.5) | 59 (27.2) | 63 (29.6) |
| Vision issues, n (%) | 115 (51.3) | 109 (50.2) | 110 (50.7) | 108 (50.7) |
| Total score (0–60) (mean, SD) | 16.4 (6.1) | 16.6 (5.6) | 16.4 (6.1) | 16.6 (5.6) |
| Mild, n (%) | 54 (24.1) | 41 (18.9) | 53 (24.4) | 40 (18.8) |
| Moderate, n (%) | 90 (40.2) | 107 (49.3) | 86 (39.6) | 105 (49.3) |
| High, n (%) | 80 (35.7) | 69 (31.8) | 78 (35.9) | 68 (31.9) |
| EQ-5D-5Lc | ||||
| Overall health state (0–100) (mean, SD) | 71.2 (18.9) | 71.5 (18.3) | 71.5 (18.6) | 71.3 (18.3) |
| Utility score (0–1) (mean, SD) | 0.6 (0.3) | 0.6 (0.3) | 0.6 (0.3) | 0.6 (0.3) |
| Reported problem | ||||
| Mobility, n (%) | 133 (59.3) | 116 (53.5) | 127 (58.5) | 116 (54.4) |
| Self-care, n (%) | 89 (39.7) | 83 (38.2) | 87 (40.1) | 83 (39.0) |
| Usual activity, n (%) | 138 (61.6) | 143 (65.9) | 133 (61.3) | 142 (66.7) |
| Pain/discomfort, n (%) | 168 (75.0) | 175 (80.6) | 163 (75.1) | 173 (81.2) |
| Anxiety/depression, n (%) | 102 (45.5) | 105 (48.4) | 100 (46.1) | 103 (48.4) |
| Short FES-Id | ||||
| Total score (0–28) (mean, SD) | 11.6 (4.8) | 11.6 (5.1) | 11.6 (4.8) | 11.7 (5.1) |
aAt least one monthly calendar/phone call completed.
bHigher scores on the FROP-Com indicate increased falls risk.
cHigher scores on the EQ-5D-5L indicate better overall health state.
dHigher scores on the FES-I indicate increased fear of falling.
Abbreviations: EQ-5D-5L, EuroQol five dimensions questionnaire; FROP-Com, Falls Risk for Older People in the Community; IQR, interquartile range; SD, standard deviation; Short FES-I, Falls Efficacy Scale–International (Short version).